MONDAY, March 17, 2025 (HealthDay News) -- The global burden of diabetic nephropathy increased from 1990 to 2021, and is ...
The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, ...
Immunoglobulin A (IgA) nephropathy, also called Berger’s disease, is an autoimmune disease that affects your kidneys. IgA is an antibody. Antibodies are proteins made by your immune system.
Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref.
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal ...
Pathological and Clinical Differences Between Bucillamine-Induced and Primary Membranous Nephropathy
The following is a summary of “Bucillamine-induced membranous nephropathy versus primary membranous nephropathy: comparing ...
Diabetic nephropathy remains a major complication of diabetes and a leading cause of end-stage renal disease worldwide. Despite advances in diabetes management, no current treatments effectively ...
IgA Nephropathy Foundation Leadership and IgAN Patients pose for a photo at SPARK IgA Nephropathy Foundation celebrates 20 years of advocac ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results from Part 2 of a Phase 1/2 clinical study of ARO-C3, the company’s investigational RNA interference (RNAi) therapeutic ...
Burden is projected to continue increasing through 2050, and is related to sociodemographic index. (HealthDay News) — The global burden of diabetic nephropathy increased from 1990 to 2021, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback